| SMILES | CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CN)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O |r,wU:111.115,131.138,95.103,84.88,68.80,52.59,30.39,20.28,8.17,2.2,137.142,153.158,154.161,171.176,191.196,wD:115.131,103.111,89.95,60.67,41.42,4.4,145.150,160.165,180.185,(26.61,-58.6,;26.58,-57.06,;27.89,-56.27,;29.25,-57.01,;27.87,-54.73,;26.53,-53.98,;25.2,-54.77,;25.23,-56.32,;23.86,-54.03,;23.83,-52.49,;25.14,-51.7,;26.49,-52.44,;27.81,-51.64,;27.79,-50.1,;29.1,-49.31,;26.44,-49.36,;25.12,-50.16,;22.54,-54.82,;21.14,-54.17,;19.88,-55.03,;21.03,-52.63,;22.3,-51.76,;22.17,-50.22,;23.34,-49.22,;22.74,-47.8,;21.21,-47.92,;20.86,-49.41,;19.63,-51.97,;18.21,-52.57,;18.02,-54.1,;16.99,-51.63,;17.18,-50.12,;18.6,-49.51,;18.79,-47.98,;20.2,-47.38,;20.4,-45.85,;19.17,-44.92,;21.81,-45.25,;15.57,-52.23,;14.34,-51.31,;14.54,-49.78,;12.94,-51.9,;12.81,-53.46,;11.14,-53.58,;10.5,-52.03,;11.77,-50.93,;11.77,-49.38,;10.41,-48.63,;13.1,-48.63,;13.08,-47.08,;14.42,-46.3,;15.76,-47.07,;14.41,-44.75,;15.73,-43.97,;17.08,-44.75,;18.42,-43.97,;17.1,-46.29,;13.07,-43.99,;13.06,-42.45,;14.39,-41.68,;11.72,-41.69,;10.4,-42.46,;10.4,-44.01,;9.07,-44.77,;11.75,-44.77,;11.73,-40.14,;10.37,-39.39,;9.05,-40.16,;10.38,-37.84,;11.71,-37.07,;13.04,-37.83,;13.06,-39.37,;14.39,-40.13,;15.71,-39.36,;17.06,-40.12,;15.72,-37.82,;14.38,-37.06,;9.03,-37.07,;9.02,-35.54,;10.36,-34.77,;7.68,-34.77,;7.69,-33.24,;6.36,-32.47,;5.02,-33.24,;6.34,-30.93,;7.68,-30.15,;5.01,-30.16,;5,-28.63,;6.32,-27.86,;3.66,-27.86,;2.32,-28.64,;2.35,-30.18,;3.67,-26.33,;2.31,-25.56,;.99,-26.34,;2.3,-24.01,;3.64,-23.23,;4.98,-24,;4.99,-25.56,;6.3,-23.23,;.97,-23.26,;.97,-21.72,;2.29,-20.94,;-.37,-20.95,;-1.7,-21.73,;-1.69,-23.27,;-3.03,-24.05,;-.35,-24.03,;-.37,-19.42,;-1.72,-18.65,;-3.04,-19.43,;-1.72,-17.11,;-3.07,-16.34,;-3.06,-14.81,;-1.75,-14.03,;-4.41,-14.04,;-5.73,-14.82,;-5.73,-16.36,;-4.47,-17.26,;-4.95,-18.72,;-6.5,-18.73,;-7.52,-19.88,;-9.02,-19.57,;-9.5,-18.1,;-8.48,-16.95,;-6.96,-17.27,;-4.41,-12.5,;-5.76,-11.74,;-7.08,-12.51,;-5.76,-10.2,;-7.11,-9.43,;-.4,-16.33,;-.41,-14.79,;.94,-17.09,;29.19,-53.93,;29.17,-52.39,;30.54,-54.67,;31.86,-53.88,;31.83,-52.34,;33.15,-51.55,;34.49,-52.29,;33.13,-50.01,;33.21,-54.62,;33.24,-56.17,;34.53,-53.83,;35.88,-54.58,;35.9,-56.11,;37.25,-56.86,;37.28,-58.4,;38.57,-56.06,;37.2,-53.78,;37.17,-52.24,;38.54,-54.52,;39.87,-53.73,;39.83,-52.18,;38.48,-51.44,;41.15,-51.4,;41.21,-54.47,;41.24,-56.01,;42.53,-53.68,;43.87,-54.42,;43.9,-55.97,;45.25,-56.71,;45.28,-58.25,;46.63,-58.99,;46.66,-60.53,;45.34,-61.32,;48.01,-61.28,;45.2,-53.63,;45.17,-52.08,;46.55,-54.37,;47.86,-53.57,;47.84,-52.03,;49.16,-51.24,;49.13,-49.7,;47.77,-48.95,;50.45,-48.91,;49.22,-54.32,;49.24,-55.86,;50.53,-53.52,;51.88,-54.27,;51.91,-55.81,;53.26,-56.56,;53.28,-58.09,;54.63,-58.84,;54.67,-60.38,;53.34,-61.18,;56.01,-61.12,;53.21,-53.48,;53.17,-51.93,;54.55,-54.22,;55.87,-53.42,;55.84,-51.88,;57.15,-51.09,;58.51,-51.83,;59.82,-51.04,;59.79,-49.5,;61.11,-48.71,;58.45,-48.76,;57.13,-49.55,;57.21,-54.17,;58.53,-53.38,;57.25,-55.7,)| |
|---|
Search and Browse
Robertson, CR; Scholl, EA; Pruess, TH; Green, BR; White, HS; Bulaj, G Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery. J Med Chem53:1871-5 (2010) [PubMed] Article